BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marciani DJ. Effects of immunomodulators on the response induced by vaccines against autoimmune diseases. Autoimmunity 2017;50:393-402. [PMID: 28906131 DOI: 10.1080/08916934.2017.1373766] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Maruszewska-cheruiyot M, Donskow-łysoniewska K, Piechna K, Krawczak K, Doligalska M. L4 stage Heligmosomoides polygyrus prevents the maturation of dendritic JAWS II cells. Experimental Parasitology 2019;196:12-21. [DOI: 10.1016/j.exppara.2018.10.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Busold S, Nagy NA, Tas SW, van Ree R, de Jong EC, Geijtenbeek TBH. Various Tastes of Sugar: The Potential of Glycosylation in Targeting and Modulating Human Immunity via C-Type Lectin Receptors. Front Immunol 2020;11:134. [PMID: 32117281 DOI: 10.3389/fimmu.2020.00134] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
3 Kabir MT, Uddin MS, Mathew B, Das PK, Perveen A, Ashraf GM. Emerging Promise of Immunotherapy for Alzheimer's Disease: A New Hope for the Development of Alzheimer's Vaccine. Curr Top Med Chem 2020;20:1214-34. [PMID: 32321405 DOI: 10.2174/1568026620666200422105156] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
4 Otero-Romero S, Rodríguez-García J, Vilella A, Ara JR, Brieva L, Calles C, Carmona O, Casanova V, Costa-Frossard L, Eichau S, García-Merino JA, Garcia-Vidal C, González-Platas M, Llaneza M, Martínez-Ginés M, Meca-Lallana JE, Prieto JM, Rodríguez-Antigüedad A, Tintoré M, Blanco Y, Moral E; en nombre del Grupo de enfermedades desmielizantes de la SEN. Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement. Neurologia (Engl Ed) 2021;36:50-60. [PMID: 32561334 DOI: 10.1016/j.nrl.2020.02.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Heidari AR, Boroumand-Noughabi S, Nosratabadi R, Lavi Arab F, Tabasi N, Rastin M, Mahmoudi M. Acylated and deacylated quillaja saponin-21 adjuvants have opposite roles when utilized for immunization of C57BL/6 mice model with MOG35-55 peptide. Mult Scler Relat Disord 2019;29:68-82. [PMID: 30685444 DOI: 10.1016/j.msard.2019.01.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
6 Nagy NA, de Haas AM, Geijtenbeek TBH, van Ree R, Tas SW, van Kooyk Y, de Jong EC. Therapeutic Liposomal Vaccines for Dendritic Cell Activation or Tolerance. Front Immunol 2021;12:674048. [PMID: 34054859 DOI: 10.3389/fimmu.2021.674048] [Reference Citation Analysis]
7 Marciani DJ. Promising Results from Alzheimer's Disease Passive Immunotherapy Support the Development of a Preventive Vaccine. Research (Wash D C) 2019;2019:5341375. [PMID: 31549066 DOI: 10.34133/2019/5341375] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
8 Antúnez LR, Pressnall MM, Berkland CJ. Adjuvants as Delivery Systems in Antigen-Specific Immunotherapies. J Pharm Sci 2019;108:3831-41. [PMID: 31526814 DOI: 10.1016/j.xphs.2019.09.011] [Reference Citation Analysis]
9 Castenmiller C, Keumatio-Doungtsop BC, van Ree R, de Jong EC, van Kooyk Y. Tolerogenic Immunotherapy: Targeting DC Surface Receptors to Induce Antigen-Specific Tolerance. Front Immunol 2021;12:643240. [PMID: 33679806 DOI: 10.3389/fimmu.2021.643240] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]